Old Web
English
Sign In
Acemap
>
Paper
>
1195P Brigatinib (BRG) vs crizotinib (CRZ) in ALK TKI–naive ALK+ NSCLC: Final results from ALTA-1L
1195P Brigatinib (BRG) vs crizotinib (CRZ) in ALK TKI–naive ALK+ NSCLC: Final results from ALTA-1L
2021
Sanjay Popat
H.R. Kim
M-J Ahn
J.C-H. Yang
J. Y. Han
Maximilian J Hochmair
K H Lee
Angelo Delmonte
M. R. Garcia-Campelo
D.W. Kim
Frank Griesinger
E. Felip
Raffaele Califano
Alexander I. Spira
Scott N. Gettinger
M. Tiseo
H-m. Lin
Y Liu
Florin Vranceanu
D.R. Camidge
Keywords:
Brigatinib
Cancer research
Crizotinib
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]